Cambridge life science rising star Nuclera is set to step up commercialisation worldwide – especially across the US and ...

An alliance with a German-based global operator promises further international expansion in the cell and gene therapies ...

Scaling a business is an aspiration shared by many entrepreneurs and executives, especially within the life sciences and technology sectors, writes Paul Hughes, Managing Director, Life Sciences & ...

The world’s largest market for keyhole surgery – spanning millions of patients – has been opened up to Cambridge pioneer CMR ...

Shift Bioscience, a Cambridge biotech using generative AI models to understand how activation of different genes can reverse ...

Poppy Gustafsson, who recently quit as CEO of Cambridge cyber security high flyer Darktrace, is to lead the UK’s Office for ...

The Prime Minister in his speech in Downing Street on 27 August warned that tough action would be necessary to ‘fix the ...

London Stansted Airport has disclosed details of a five-year £1.1 billion investment programme designed to deliver ...

A surge of US deals boosted first half revenues for Cambridge-based location software company 1Spatial. Revenue was up five ...

Cambridge Judge Business School and Cranfield School of Management are among six organisations promoting new MBA scholarships ...

Proteotype Diagnostics, a cancer detection startup based in Cambridge, is planning staged global growth in terms of headcount ...

Cambridge-based clock.bio, a healthspan biotech working to reverse ageing, has raised $5.3 million seed funding led by ...